Home
Stock Ideas
Long Ideas
Healthcare
Summary
RadNet’s advanced imaging mix is improving as faster scanners help its centers handle more complex exams.
Their DeepHealth software has also secured larger external contracts, which shows it can sell well beyond RDNT’s own centers.
In that sense, ONRAD’s hospital relationships should give RDNT yet another route to sell DeepHealth alongside radiology services.
Thus, I reiterate my “Strong Buy” on RDNT, especially since its valuation remains at very reasonable levels despite its strong growth momentum.
TommL/E+ via Getty Images
RadNet, Inc. ( RDNT ) is a diagnostic imaging and healthcare technology company. What’s unique about RDNT is that it combines patient-facing services (i.e., outpatient imaging exams) with software that’s designed to improve how medical images are acquired, interpreted, and managed.…